BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mourad L, El-Ahwany E, Zoheiry M, Abu-Taleb H, Hassan M, Ouf A, Rahim AA, Hassanien M, Zada S. Expression analysis of liver-specific circulating microRNAs in HCV-induced hepatocellular Carcinoma in Egyptian patients. Cancer Biol Ther 2018;19:400-6. [PMID: 29333940 DOI: 10.1080/15384047.2018.1423922] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Guo X, Guo A. Profiling circulating microRNAs in serum of Fasciola gigantica-infected buffalo. Mol Biochem Parasitol 2019;232:111201. [PMID: 31377228 DOI: 10.1016/j.molbiopara.2019.111201] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
2 Li X, Zhang W, Xu K, Lu J. miR-34a promotes liver fibrosis in patients with chronic hepatitis via mediating Sirt1/p53 signaling pathway. Pathol Res Pract 2020;216:152876. [PMID: 32089410 DOI: 10.1016/j.prp.2020.152876] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Cozma A, Fodor A, Vulturar R, Sitar-Tăut AV, Orăşan OH, Mureşan F, Login C, Suharoschi R. DNA Methylation and Micro-RNAs: The Most Recent and Relevant Biomarkers in the Early Diagnosis of Hepatocellular Carcinoma. Medicina (Kaunas) 2019;55:E607. [PMID: 31546948 DOI: 10.3390/medicina55090607] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
4 Tadokoro T, Morishita A, Masaki T. Diagnosis and Therapeutic Management of Liver Fibrosis by MicroRNA. Int J Mol Sci 2021;22:8139. [PMID: 34360904 DOI: 10.3390/ijms22158139] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Krupa R, Malecki W, Czarny P, Strycharz J, Jablkowski M, Kordek R, Szemraj J, Sliwinski T. MicroRNA profile and iron-related gene expression in hepatitis C-related hepatocellular carcinoma: a preliminary study. Arch Med Sci 2021;17:1175-83. [PMID: 34522246 DOI: 10.5114/aoms.2019.86613] [Reference Citation Analysis]
6 Mjelle R, Dima SO, Bacalbasa N, Chawla K, Sorop A, Cucu D, Herlea V, Sætrom P, Popescu I. Comprehensive transcriptomic analyses of tissue, serum, and serum exosomes from hepatocellular carcinoma patients. BMC Cancer 2019;19:1007. [PMID: 31660891 DOI: 10.1186/s12885-019-6249-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
7 Loosen SH, Castoldi M, Jördens MS, Roy S, Vucur M, Kandler J, Hammerich L, Mohr R, Tacke F, Ulmer TF, Neumann UP, Luedde T, Roderburg C. Serum levels of circulating microRNA-107 are elevated in patients with early-stage HCC. PLoS One 2021;16:e0247917. [PMID: 33711036 DOI: 10.1371/journal.pone.0247917] [Reference Citation Analysis]
8 Aly DM, Gohar NA, Abd El-Hady AA, Khairy M, Abdullatif MM. Serum microRNA let-7a-1/let-7d/let-7f and miRNA 143/145 Gene Expression Profiles as Potential Biomarkers in HCV Induced Hepatocellular Carcinoma. Asian Pac J Cancer Prev 2020;21:555-62. [PMID: 32102538 DOI: 10.31557/APJCP.2020.21.2.555] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
9 Jin X, Zhang Y, Wang H, Zhang Y. Expression and Clinical Values of Serum miR-155 and miR-224 in Chinese Patients with HCV Infection. IJGM 2022;Volume 15:1393-403. [DOI: 10.2147/ijgm.s344345] [Reference Citation Analysis]
10 Zubillaga-Guerrero MI, Illades-Aguiar B, Flores-Alfaro E, Castro-Coronel Y, Jiménez-Wences H, Patiño EIL, Pérez KIG, Del Carmen Alarcón-Romero L. An increase of microRNA-16-1 is associated with the high proliferation of squamous intraepithelial lesions in the presence of the integrated state of HR-HPV in liquid cytology samples. Oncol Lett 2020;20:104. [PMID: 32831923 DOI: 10.3892/ol.2020.11965] [Reference Citation Analysis]
11 Abdel-Al A, El-Ahwany E, Zoheiry M, Hassan M, Ouf A, Abu-Taleb H, Abdel Rahim A, El-Talkawy MD, Zada S. miRNA-221 and miRNA-222 are promising biomarkers for progression of liver fibrosis in HCV Egyptian patients. Virus Res 2018;253:135-9. [PMID: 29932949 DOI: 10.1016/j.virusres.2018.06.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
12 Salomão KB, Pezuk JA, de Souza GR, Chagas P, Pereira TC, Valera ET, Brassesco MS. MicroRNA dysregulation interplay with childhood abdominal tumors. Cancer Metastasis Rev 2019;38:783-811. [PMID: 31848768 DOI: 10.1007/s10555-019-09829-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
13 Lorini S, Gragnani L, Zignego AL. The Relevance of MicroRNAs in the Pathogenesis and Prognosis of HCV-Disease: The Emergent Role of miR-17-92 in Cryoglobulinemic Vasculitis. Viruses 2020;12:E1364. [PMID: 33260407 DOI: 10.3390/v12121364] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Nomair AM, Issa NM, Madkour MA, Shamseya MM. The clinical significance of serum miRNA-224 expression in hepatocellular carcinoma. Clin Exp Hepatol 2020;6:20-7. [PMID: 32166120 DOI: 10.5114/ceh.2020.93052] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
15 Yasser MB, Abdellatif M, Emad E, Jafer A, Ahmed S, Nageb L, Abdelshafy H, Al-Anany AM, Al-Arab MAE, Gibriel AA. Circulatory miR-221 & miR-542 expression profiles as potential molecular biomarkers in Hepatitis C Virus mediated liver cirrhosis and hepatocellular carcinoma. Virus Res 2021;296:198341. [PMID: 33607184 DOI: 10.1016/j.virusres.2021.198341] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Hany NM, Hammouda AMA, Nabih ES, Mohamed SM. The potential regulatory role of miR16 to the interplay between interferon and transforming growth factor beta pathways through IRF3 and SMAD7 in hepatitis C virus infected patients. J Cell Biochem 2019;120:12694-701. [PMID: 30861602 DOI: 10.1002/jcb.28537] [Reference Citation Analysis]
17 Yang L, Wei C, Li Y, He X, He M. miR-224 is an early-stage biomarker of hepatocellular carcinoma with miR-224 and miR-125b as prognostic biomarkers. Biomark Med 2020;14:1485-500. [PMID: 33155836 DOI: 10.2217/bmm-2020-0099] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Wang X, Lu J, Cao J, Ma B, Gao C, Qi F. MicroRNA-18a promotes hepatocellular carcinoma proliferation, migration, and invasion by targeting Bcl2L10. Onco Targets Ther. 2018;11:7919-7934. [PMID: 30519035 DOI: 10.2147/ott.s180971] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Zan Y, Wang B, Liang L, Deng Y, Tian T, Dai Z, Dong L. MicroRNA-139 inhibits hepatocellular carcinoma cell growth through down-regulating karyopherin alpha 2. J Exp Clin Cancer Res 2019;38:182. [PMID: 31046781 DOI: 10.1186/s13046-019-1175-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]